 |
|
 |
|
       |
|
|
|
|
|
|
|
A Coller IP Management client, Prosonix Ltd (Oxford, UK), has successfully completed a £5 million total funding round designed to underpin and drive the accelerated future growth plans of the business. Prosonix is an acknowledged leader in the commercialization of proprietary ultrasonic particle engineering technologies and added value ultrasonic process chemistry solutions for the pharmaceutical and related industries.
Underpinning Prosonix’s business is a well developed IP portfolio which has been built up over the last 7 years and is becoming commercialized. The Coller IP Management patent attorney team led by Peter Mansfield has played a key role in the design and implementation of the IP protection process used by Prosonix throughout the period.
Prosonix CEO David Hipkiss said “Today is a very significant milestone in Prosonix’s development. Following the funding Prosonix will have a very strong balance sheet from which we will be able to accelerate our growth plans to build an exciting and long term profitable business serving our customers in the worldwide pharmaceutical and chemical industries. The IP underpinning our business together with an efficient, proactive and pragmatic process for its management are fundamental to our future success.”
4 December 2007
